Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 96%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,003
Total Claims
$1.2M
Drug Cost
477
Beneficiaries
$2,607
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+185%
Opioid rate vs peers
6.4% vs 2.2% avg
+85%
Cost per patient vs peers
$2,607 vs $1,411 avg
+33%
Brand preference vs peers
14.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
6.4%
Opioid Rate
893
Opioid Claims
$49K
Opioid Cost
9.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,956 claims · $997K
Generic: 11,886 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Aspart | 149 | $134K |
| Apixaban | 174 | $113K |
| Sitagliptin Phosphate | 127 | $100K |
| Empagliflozin | 83 | $76K |
| Dulaglutide | 35 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 69 | $42K |
| Insulin Detemir | 69 | $41K |
| Dapagliflozin Propanediol | 27 | $20K |
| Insulin Lispro | 20 | $19K |
| Brexpiprazole | 12 | $18K |
| Oxycodone Hcl | 13 | $18K |
| Fluticasone Propion/Salmeterol | 39 | $17K |
| Exenatide Microspheres | 14 | $15K |
| Rivaroxaban | 23 | $13K |
| Linagliptin | 23 | $13K |
Prescribing Profile
Patient Profile
72
Avg Age
52%
Female
1.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About